What is Suraksha Diagnostic Ltd (SURAKSHA) share price return in the past 10 years?

Data is not available for this company

What is the share price of Suraksha Diagnostic Ltd (SURAKSHA)?

Company share prices are keep on changing according to the market conditions. The current trading price of Suraksha Diagnostic Ltd (SURAKSHA) on 02-Jul-2026 16:59:59 at 16:59 is 271.30.

What is the P/E ratio of Suraksha Diagnostic?

The latest standalone P/E ratio of Suraksha Diagnostic as of 02-Jul-2026 is 41.48.

What is the P/B ratio of Suraksha Diagnostic Ltd (SURAKSHA)?

The latest standalone P/B ratio of Suraksha Diagnostic Ltd (SURAKSHA) as of 02-Jul-2026 is 5.66.

What is the 52-week high and low of Suraksha Diagnostic Ltd (SURAKSHA)?

The 52-week high of Suraksha Diagnostic Ltd (SURAKSHA) is Rs. 333.65 and the 52-week low is Rs. 224.10.

Suraksha Diagnostic Ltd (SURAKSHA) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Suraksha Diagnostic Ltd (SURAKSHA)
Brand: Suraksha Diagnostic

Key Metrics

Valuation Multiples

Market Cap

₹1,413 Cr.

Current Price

₹271.3

52-Week Low / High

₹224 / 334

TTM EPS

₹6.2

TTM Sales

₹310 Cr.

Book Value per Share

₹47

P/E Ratio

43.90

Lower than its 5-year historical median

Industry PE

93.2

Price to Book (P/B)

5.77

Lower than its 5-year historical median

Price to Sales (P/S)

4.55

Lower than its 5-year historical median

EV/EBITDA

14.09

Lower than its 5-year historical median

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

15.93%

Outperforms industry median

Return on Capital Employed (ROCE)

24.92%

Outperforms industry median

Return on Assets (ROA)

9.78%

Operating Profit Margin

32.6%

Net Profit Margin

12.29%

Gross Profit Margin

30.4%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

15.26%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

15.59%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

33.94%

Asset Quality

Promoter Holding

49.10%

Pledged shares (%) of Promoter's holding (%)

0.10%

Reserves

₹234 Cr.

Equity

₹10.4 Cr.

Face Value

₹2

All Time Low / High

₹224.10 / 449.00

Suraksha Diagnostic stock performance

Key Ratios

Check Before You Invest

Quality

Very Good

Check detailed performance

Valuation

Fair

Check Valuation charts

Price Trend

Semi Strong

Check Price chart

Q.1 Is Suraksha Diagnostic Ltd a good quality company?

Suraksha Diagnostic Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Suraksha Diagnostic Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Suraksha Diagnostic Ltd vs industry peers?

Suraksha Diagnostic Ltd revenue CAGR is 9.86%, compared to the industry median CAGR of 1.38%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Suraksha Diagnostic Ltd?

Promoters hold 49.10% of the Suraksha Diagnostic Ltd, with 0.10% of their stake pledged, indicating low pledge risk.

Q.1 Stock return of Suraksha Diagnostic Ltd over the last decade?

Over the last 1 year(s), the stock has delivered a CAGR of -6.73% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'12	Mar'13	Mar'15	Mar'16	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	0%	0%	16.8%	16.1%	20.2%	6%	22.7%	9.6%	22.9%	24.9%	-
Value Creation Index ⓘ	NA	NA	0.2	0.2	0.4	-0.6	0.6	-0.3	0.6	0.8	-
Growth Parameters ⓘ
Sales ⓘ	0	0	70.2	99.1	158	140	223	190	219	252	310
Sales YoY Gr.	-	NA	NA	41.2%	58.9%	-11.1%	59.4%	-14.8%	15%	15.3%	-
Adj EPS ⓘ	0	0	109.3	78.4	217.5	115.1	358.5	119.1	372.1	6.1	6.2
YoY Gr.	-	NA	NA	-28.3%	177.3%	-47.1%	211.4%	-66.8%	212.4%	-98.4%	-
BVPS (₹) ⓘ	0	0	695.5	775.2	1,712.5	1,805.7	2,149.9	2,236.2	2,576.5	40.5	47
Adj Net Profit ⓘ	0	0	7.5	5.4	15	7.9	24.7	8.2	25.7	32	32
Cash Flow from Ops. ⓘ	0	0	19.5	13.5	31.3	23.5	42.3	44.1	60.5	63.4	-
Debt/CF from Ops. ⓘ	0	0	1.5	3.1	0.4	0.7	0.5	0.3	0.1	0.1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	9.9%	4.1%	15.3%
Adj EPS ⓘ	NA	-51%	-74.2%	-98.4%
BVPSⓘ	NA	-52.7%	-73.4%	-98.4%
Share Price	-	-	-	-15.8%

Key Financial Parameters ⓘ

	Mar'15	Mar'16	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	15.3	10.4	17.2	6.5	17.9	5.4	15.3	16.4	14.1
Op. Profit Mgn % ⓘ	24.8	22.2	21.7	17.9	22.2	24.6	33.4	32.6	30.7
Net Profit Mgn % ⓘ	10.7	5.5	9.5	5.7	11.1	4.1	11.5	12.4	10.4
Debt to Equity ⓘ	0.6	0.8	0.1	0.1	0.1	0.1	0.1	0	0
Working Cap Days ⓘ	0	78	69	101	98	102	51	81	38
Cash Conv. Cycle ⓘ	0	-61	-30	-34	-13	-11	-13	-3	10

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'15	Mar'16	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	70	99	157	140	223	190	219	252
Operating Expenses ⓘ +	53	77	123	117	175	146	148	170
Manufacturing Costs	5	6	13	5	38	47	49	61
Material Costs	9	14	21	26	60	27	27	30
Employee Cost	11	19	32	23	34	40	40	43
Other Costs ⓘ	27	39	58	63	43	32	31	36
Operating Profit ⓘ	17	22	34	23	48	44	71	82
Operating Profit Margin (%)	24.8%	22.2%	21.7%	16.2%	21.5%	23.4%	32.4%	32.5%
Other Income ⓘ +	1	1	2	1	2	4	4	4
Exceptional Items ⓘ	-0	0	0	0	0	0	-1	0
Interest ⓘ	1	4	2	2	2	10	10	9
Depreciation ⓘ	6	9	13	16	15	32	33	35
Profit Before Tax ⓘ	12	10	21	6	33	7	31	41
Tax ⓘ	4	5	6	-0	9	1	8	10
Profit After Tax	8	5	15	6	24	6	23	31
PAT Margin (%)	10.8%	5.6%	9.7%	4.6%	10.6%	3.2%	10.6%	12.3%
Adjusted EPS (₹)	109.6	79.7	220.5	93.3	344.2	94.4	342.4	6.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Suraksha Diagnostic - Consolidated

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'15	Mar'16	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	49	55	120	126	150	156	179	211
Share Capital ⓘ	8	8	9	9	9	9	9	10
Reserves ⓘ	41	47	111	118	141	147	171	201
Debt +	23	33	8	16	19	8	5	3
Long Term Debt	19	29	8	10	12	8	5	3
Short Term Debt	4	4	0	7	7	0	0	0
Minority Interest	0	0	0	0	0	-0	-0	-1
Trade Payables	13	10	13	13	14	14	14	14
Others Liabilities ⓘ	19	28	32	16	18	103	101	107
Total Liabilities ⓘ	104	125	173	171	201	281	300	334
Fixed Assets
Net Fixed Assets ⓘ +	73	91	128	119	119	195	212	223
Gross Block	88	116	194	198	211	226	274	319
Accumulated Depreciation	15	24	67	79	92	31	62	96
CWIP ⓘ	0	0	0	0	1	2	1	11
Investments ⓘ	0	0	5	5	0	0	0	1
Inventories	2	4	5	4	6	6	7	8
Trade Receivables	3	5	6	6	8	5	9	14
Cash Equivalents	12	9	4	4	3	55	55	20
Others Assets ⓘ	13	16	24	32	64	18	17	57
Total Assets ⓘ	104	125	173	171	201	281	300	334

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'15	Mar'16	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	20	13	31	24	42	44	60	63
PBT ⓘ	12	10	21	6	33	7	31	41
Adjustment ⓘ	6	12	14	21	16	40	41	43
Changes in Working Capital ⓘ	4	-6	3	-3	-2	5	-4	-10
Tax Paid ⓘ	-3	-3	-7	-2	-4	-7	-9	-11
Cash Flow From Investing Activity ⓘ +	-42	-26	-20	-28	-44	-21	-35	-40
Capex	-40	-27	-16	-15	-19	-13	-43	-42
Net Investments	-4	-9	-3	-5	-27	-11	5	-1
Others ⓘ	2	10	-1	-7	2	3	3	4
Cash Flow From Financing Activity ⓘ +	17	10	-10	3	1	-24	-25	-24
Net Proceeds from Shares ⓘ	2	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-1	-4	-2	-2	-2	-1	-1	-1
Dividend Paid ⓘ	0	0	0	0	0	0	0	0
Others ⓘ	16	14	-9	5	3	-23	-24	-23
Net Cash Flow ⓘ	-6	-3	1	-1	-0	-1	0	-0

Financial Ratio

PARTICULARS	Mar'15	Mar'16	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	15.76	10.84	17.73	5.3	17.4	4.01	13.93	15.93
ROCE (%)	16.8	16.12	20.19	6.04	22.65	9.62	22.94	24.92
Asset Turnover Ratio	0.68	0.87	1.06	0.81	1.2	0.79	0.75	0.8
PAT to CFO Conversion(x)	2.5	2.6	2.07	4	1.75	7.33	2.61	2.03
Working Capital Days
Receivable Days	13.90	13.30	12.20	15.60	11.10	11.80	11.30	16.40
Inventory Days	11.10	11.10	10.80	12.90	8.70	11.90	10.70	10.70
Payable Days	487.40	290.80	196.30	181.60	80	185.90	190.40	173.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

0.10

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Suraksha Diagnostic Ltd FAQs

The current trading price of Suraksha Diagnostic on 02-Jul-2026 16:59 is ₹271.3.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jul-2026 the market cap of Suraksha Diagnostic stood at ₹1,413 Cr

The latest P/E ratio of Suraksha Diagnostic as of 01-Jul-2026 is 41.48.

The latest P/B ratio of Suraksha Diagnostic as of 01-Jul-2026 is 5.66.

The 52-week high of Suraksha Diagnostic is ₹333.6 and the 52-week low is ₹224.1.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Suraksha Diagnostic is ₹301 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Suraksha Diagnostic Ltd is a good quality company.

The key valuation ratios of Suraksha Diagnostic Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Suraksha Diagnostic Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Suraksha Diagnostic Ltd

Suraksha Diagnostic Limited was incorporated as ‘Suraksha Diagnostic Private Limited’ as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata (RoC). Subsequently, the company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of its Shareholders held on June 5, 2024, and consequently, the name of the company was changed to ‘Suraksha Diagnostic Limited’, and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.

The company offers one-stop integrated solutions for pathology and radiology testing and medical consultation services including X-rays, ultrasonography, computerized tomography, magnetic resonance imaging scans and vaccination services through its operational network, consisting of its flagship central reference laboratory, 8 satellite laboratories (co-located with its diagnostic centers) and 215 customer touchpoints which include 49 diagnostic centres, and 166 sample collection centres (primarily franchised), as of June 30, 2024 across the states of West Bengal, Bihar, Assam, and Meghalaya. It generates revenue primarily through sales of its diagnostic services. It also provides vaccination services, and a broad spectrum of customized test packages, aimed at prediction/early detection of diseases.

In addition to integrated pathology and radiology testing services, it also offers omnichannel medical consultation services via online and offline modes to its customers. The doctors at its polyclinics range across specialties and super-specialties such as cardiology, pediatrics, dermatology, rheumatology, oncology, and nephrology. Its model of polyclinic chambers housed in diagnostic centres providing medical consultation services enables patient convenience through holistic integration of services and offering it the first right to a patient’s prescription leading to higher cross-selling opportunities to the company. It derives the majority of its revenues from the B2C segment.

Business area of the company

The company is primarily engaged in the business of running diagnostic centres for carrying out various pathological and radiological services.

Diagnostic services of the company

Routine pathology tests
Specialized pathology tests
Basic and intermediate radiology tests
Advanced radiology tests
Preventive and wellness services

Awards, accreditations, and recognition

2017: Best quality in service delivery awarded by ABP News.
2019: Best customer service in healthcare awarded by ABP News.
2021: Business Leader of the Year organised by World Leadership Congress & Awards and certificate of excellence at the Health Conclave 2021 organised by Zee24 Ghanta.
2022: Awarded the outstanding diagnostic chain of eastern Indian by ABP Ananda.
2023: Certificate of excellence in exemplary trust and commitment towards diagnostic services at the Health Conclave 2023 organised by Zee24 Ghanta.

History and milestones

2007: Launched the first centre of the Company at Kestopur, West Bengal.
2010: Launched centre at Khardah, West Bengal and number of operating centres increased to 5.
2013: Received first round of funding of Rs 300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.
2016: Number of laboratories increased to 4 and number of operating centres increased to 25.
2016: Received second round of funding of Rs 200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from the Company.
2017: Acquired the business of Sunwell Diagnostic Private Limited for a consideration of Rs 30 million.
2019: Expansion of its operations to Meghalaya through a public-private partnership with the Government of Meghalaya.
2020: Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of Rs 67 million.
2023: Established its first 3T MRI and 128 CT at New Town.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Suraksha Diagnostic Ltd (SURAKSHA)

Suraksha Diagnostic Ltd (SURAKSHA)

Suraksha Diagnostic stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Suraksha Diagnostic - Consolidated

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Suraksha Diagnostic Ltd FAQs

What is the share price of Suraksha Diagnostic?

What is the market cap of Suraksha Diagnostic?

What is the P/E ratio of Suraksha Diagnostic?

What is the P/B ratio of Suraksha Diagnostic?

What is the 52-week high and low of Suraksha Diagnostic?

What is the TTM revenue of Suraksha Diagnostic?

Is Suraksha Diagnostic Ltd a good quality company?

Is Suraksha Diagnostic Ltd undervalued or overvalued?

Is Suraksha Diagnostic Ltd a good buy now?

About Suraksha Diagnostic Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.